Evidence map›Paper›PMID 26363853›Full record

ArticleAging2015

PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.

Aleksandra Dabrowska, Jose Luis Venero, Ryota Iwasawa, Mohammed-Khair Hankir, Sunniyat Rahman, Alan Boobis, Nabil Hajji

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. PMCell biochemistry and biophysics · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Increased cytotoxicity of PbEnvironmental science. Processes & impacts · 2023
    Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Aleksandra DabrowskaImperial College London, Centre for Pharmacology and Therapeutics, Department of Medicine, London, United Kingdom.
Jose Luis VeneroDepartamento de Bioquímica y Biología Molecular. Facultad de Farmacia, Universidad de Sevilla, C/Prof. García González, Sevilla, Spain.
Ryota IwasawaImperial College London, Centre for Pharmacology and Therapeutics, Department of Medicine, London, United Kingdom.
Mohammed-Khair HankirIntegrated Research and Treatment Centre for Adiposity Diseases, Department of Medicine, University of Leipzig, Leipzig, Germany.
Sunniyat RahmanImperial College London, Centre for Pharmacology and Therapeutics, Department of Medicine, London, United Kingdom.
Alan BoobisImperial College London, Centre for Pharmacology and Therapeutics, Department of Medicine, London, United Kingdom.
Nabil HajjiImperial College London, Centre for Pharmacology and Therapeutics, Department of Medicine, London, United Kingdom.
Imperial College London · GBIFB Adiposity Diseases · DEUniversidad de Sevilla · ES

Funding

Medical Research Council
6 · The paper itself

Abstract

Due to its role in regulation of mitochondrial function, PGC1α is emerging as an important player in ageing and neurodegenerative disorders. PGC1α exerts its neuroprotective effects by promoting mitochondrial biogenesis (MB) and functioning. However, the precise regulatory role of PGC1α in the control of mitochondrial dynamics (MD) and neurotoxicity is still unknown. Here we elucidate the role of PGC1αin vitro and in vivo in the regulatory context of MB and MD in response to lead (II) acetate as a relevant model of neurotoxicity. We show that there is an adaptive response (AR) to lead, orchestrated by the BAP31-calcium signalling system operating between the ER and mitochondria. We find that this hormetic response is controlled by a cell-tolerated increase of PGC1α expression, which in turn induces a balanced expression of fusion/fission genes by binding to their promoters and implying its direct role in regulation of MD. However, dysregulation of PGC1α expression through either stable downregulation or overexpression, renders cells more susceptible to lead insult leading to mitochondrial fragmentation and cell death. Our data provide novel evidence that PGC1α expression is a key regulator of MD and the maintenance of tolerated PGC1α expression may offer a promising strategy for neuroprotective therapies.

Indexed as

AgingAnimalsApoptosisCell DeathCell LineDopaminergic NeuronsEndoplasmic ReticulumLead Poisoning, Nervous SystemMembrane ProteinsMitochondrial DynamicsNeuroprotective AgentsOrganelle BiogenesisOrganometallic CompoundsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRatsSignal TransductionBcap31 protein, ratlead acetateMembrane ProteinsNeuroprotective AgentsOrganometallic CompoundsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanTranscription FactorsBAP3calciumDrp1Leadmitochondrial biogenesis and dynamicsneurotoxicityPGC-1α

Identifiers

PMID26363853
PMCPMC4600622
OpenAlexW2172873243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.